Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

April 2018

Update to Bariatric Surgeries Prior Authorization Policy

Effective for dates of service beginning April 15, 2018, Harvard Pilgrim is updating our prior authorization policy for bariatric surgery to require confirmation by a specialist of the presence of certain medical conditions and completion of a medically supervised weight loss and exercise program within a given time frame.

Harvard Pilgrim covers medically necessary bariatric surgery with prior authorization and requires that members receive this procedure at one of the in-network facilities that have been designated as a Weight Loss Surgery Center of Excellence. Information about this program — which is designed to ensure that members receive care that is focused on patient health and safety — can be found in the Weight Loss Surgery Centers of Excellence (COEs) section of our provider website.

Confirmation by specialist

The existing bariatric surgery prior authorization policy requires that medical record documentation confirm either a body mass index (BMI) of 40 or more or a BMI of 35 and the presence of a comorbid condition (from among those listed in the policy). Beginning April 15, 2018, if the patient has one of the following conditions, confirmation must be provided by a physician with the applicable specialty, as indicated below:

  • Type II Diabetes – with documentation of diabetes diagnosis consistent with the American Diabetic Association; diagnosis must also be confirmed by an endocrinologist or primary care physician
  • Pseudotumor cerebri — diagnosis confirmed and treatment plan supported by neurologist
  • Severe arthropathy of spine and/or weight-bearing joints (when obesity prohibits appropriate surgical management of joint dysfunction treatable but for the obesity) — diagnosis must be confirmed by orthopedic surgeon
  • Obesity-induced cardiomyopathy — diagnosis must be confirmed by a cardiologist
    Obesity-related hypoventilation — diagnosis must be confirmed by a pulmonologist

If your patient has one of these diagnoses, when requesting authorization please submit the patient’s medical record or other documentation that supports that the diagnosis has been made by the appropriate provider. The list above highlights only those conditions requiring confirmation by a specialist and is not inclusive of all comorbid conditions that meet medical criteria; for complete details, please refer to the updated Bariatric Surgeries Medical Review Criteria.

Medically supervised weight loss and exercise program

In addition, under the updated policy, the requesting provider must provide documentation confirming that the patient has completed at least 6 months of a medically supervised weight loss and exercise program in which at least three months are consecutive.

Requesting authorization

We have updated our Bariatric Surgery Prior Authorization Request Form to reflect these changes. To request authorization, please fax the completed form to 800-232-0816.

    Email this article to a colleague   

    Network Matters Archives

    Download printer-friendly version


    Reminder: Medical Drugs & Buy-and-Bill or Specialty Pharmacy


    Cochlear Implants to Require Prior Authorization

    Update to Bariatric Surgeries Prior Authorization Policy

    New Bunionectomy Medical Review Criteria

    Harvard Pilgrim Adding Coverage for Newly Approved Medications

    Tips for Efficient Pharmacy Prior Authorization Process

    Complex Case Management Services

    Disease Management Programs Reinforce Physician Treatment Plans

    Updates to Medical Policies and Prior Authorization Criteria

    Policy Update: Replacement of the First Metatarsophalangeal Joint

    Updates to Implantable Neurostimulators Medical Review Criteria

    Corneal Collagen Cross-Linking Now Covered

    New Prior Authorization Policy for Hemlibra

    New Prior Authorization Policy for Imfinzi

    Substance Use Disorder: Treatment and Helpful Resources

    P&T Committee Meeting Update


    Payment Policy Updates: DME and Orthotic and Prosthetic Devices

    Medical Records: Common Issues and Quick Fixes


    Eric H. Schultz,
    President and Chief Executive Officer

    Robert Farias,
    Senior Vice President, Corporate Network Strategy

    Annmarie Dadoly,

    Joseph O'Riordan,

    Kristin Edmonston,
    Production Coordinator